Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03874039 · ClinicalTrials.gov registry record
Sweat and Gas Sensor for Healthy Skin and Atopic Dermatitis
A clinical trial of Atopic Dermatitis and Healthy Adults, sponsored by Northwestern University.
- Completed
- Registry status
- 20
- Enrollment target
- 1
- Study location
NCT03874039 is a study of Atopic Dermatitis and Healthy Adults that has completed, run by Northwestern University. The registered enrollment target is 20 participants, below the 609-participant average among 150 other Atopic Dermatitis trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03874039, a study of Atopic Dermatitis and Healthy Adults, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
Pilot study of a wearable gas and sweat skin sensor
Conditions Studied
Interventions
- DEVICE Gas sensor
- DEVICE Sweat Sensor
Study Locations (1)
Illinois
- Northwestern University - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2019-01-15 |
| Est. Completion | 2021-08-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03874039
The ClinicalTrials.gov registry entry for NCT03874039 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 609-participant average among 150 other Atopic Dermatitis trials with a reported enrollment target (97% lower). The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Atopic Dermatitis appearing as the primary indexed condition, and to 2 interventions - of which Gas sensor is the first listed.
NCT03874039 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT03874039 about?
NCT03874039 is a clinical study titled "Sweat and Gas Sensor for Healthy Skin and Atopic Dermatitis". Pilot study of a wearable gas and sweat skin sensor
What is the current status of trial NCT03874039?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2019-01-15. Estimated completion is 2021-08-10.
What conditions does trial NCT03874039 study?
This clinical trial studies the following conditions: Atopic Dermatitis, Healthy Adults, Wearables, Sweat Sensor, Gas Sensor.
What interventions are being tested in trial NCT03874039?
The interventions under investigation include: Gas sensor (DEVICE), Sweat Sensor (DEVICE).
Who is sponsoring clinical trial NCT03874039?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03874039 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Atopic Dermatitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Registry for Systemic Eczema Treatments
RECRUITING
-
An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis (AD)
RECRUITING
-
An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis Exposed to Ruxolitinib Cream Versus Topical Corticosteroids During Pregnancy: A US Claims Database Analysis
RECRUITING
-
A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
RECRUITING · Phase 2
-
Evaluating the Safety and Tolerability of Baricitinib in Patients With Job Syndrome With Lupus-Like Disease and/or Atopic Dermatitis
RECRUITING · Phase 1
-
Using Dupilumab to Improve Circadian Function, Sleep and Pruritus in Children With Moderate/Severe Atopic Dermatitis
RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.